| Literature DB >> 27165066 |
E S Gershtein1, E R Isaeva2, D N Kushlinsky3, E A Korotkova2, V D Ermilova2, K P Laktionov2, L V Adamyan3.
Abstract
IGF-1, IGF-2, and IGFBP-1,2,3 were assayed in blood serum of patients with malignant ovarian tumors (n=44), borderline ovarian tumors (n=11), and benign ovarian tumors (n=12) as well as in healthy women (n=33). In blood serum of patients with malignant ovarian tumors, the level of IGF-1 was lower and IGFBP-1 was higher than in other groups. In patients with malignant and borderline ovarian tumors, the level of IGFBP-2 was higher than in healthy women and in patients with benign ovarian tumors. There was no correlation between most examined parameters and the clinical and morphological peculiarities of ovarian tumors. The study revealed IGF/IGFBP imbalance in patients with malignant ovarian tumor and showed that IGFBP-2 proved to be a potential diagnostic serological marker w with 90% sensitivity and 90% specificity.Entities:
Keywords: IGF-binding proteins IGFBP-1, 2, 3; insulin-like growth factors IGF-1 and IGF-2; ovarian tumors
Mesh：
Substances：
Year: 2016 PMID： 27165066 DOI： 10.1007/s10517-016-3317-2
Source DB: PubMed Journal: Bull Exp Biol Med ISSN： 0007-4888 Impact factor: 0.804